Patents Assigned to Sentient Lifesciences, Inc.
  • N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress
    Patent number: 10869846
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: December 22, 2020
    Assignee: SENTIENT LIFESCIENCES, INC.
    Inventor: Glenn A. Goldstein
  • USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF DISEASE AND INJURY
    Publication number: 20150148423
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of various disorders
    Type: Application
    Filed: April 26, 2013
    Publication date: May 28, 2015
    Applicant: SENTIENT LIFESCIENCES, INC.
    Inventor: Glenn A. Goldstein
  • N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
    Patent number: 8993627
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: March 31, 2015
    Assignee: Sentient LifeSciences, Inc.
    Inventor: Glenn A. Goldstein
  • N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
    Patent number: 8937099
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: January 20, 2015
    Assignee: Sentient Lifesciences, Inc.
    Inventor: Glenn A. Goldstein